BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mavilia MG, Wu GY. HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation. J Clin Transl Hepatol 2018;6:296-305. [PMID: 30271742 DOI: 10.14218/JCTH.2018.00016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Su Y, Chang M, Chien R, Liaw Y. Hepatitis C Virus Reactivation in Anti-HCV Antibody-Positive Patients with Chronic Hepatitis B Following Anti-HBV Therapies. Viruses 2022;14:1858. [DOI: 10.3390/v14091858] [Reference Citation Analysis]
2 Tseng C, Liu W, Ko P, Chen Y, Tseng K, Chang T. The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients. Viruses 2022;14:1812. [DOI: 10.3390/v14081812] [Reference Citation Analysis]
3 Naderi M, Hosseini SM, Behnampour N, Shahramian I, Moradi A. Determining the Prevalence of Hepatitis Delta Virus, Hepatitis C Virus, and HIV Among Mothers and Infants with Hepatitis B Virus Chronic Infection. Jundishapur J Microbiol 2022;15. [DOI: 10.5812/jjm-127879] [Reference Citation Analysis]
4 Said ZNA, El-Sayed MH. Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings. World J Hepatol 2022; 14(7): 1333-1343 [DOI: 10.4254/wjh.v14.i7.1333] [Reference Citation Analysis]
5 Ahmed Z, Shetty A, Victor DW, Kodali S. Viral hepatitis: A narrative review of hepatitis A–E. World J Meta-Anal 2022; 10(3): 99-121 [DOI: 10.13105/wjma.v10.i3.99] [Reference Citation Analysis]
6 Liu S, Zhao K, Su X, Gao X, Yao Y, Kong R, Wang Y, Wu C, Lu M, Chen X, Pei R. Enhanced host immune responses in presence of HCV facilitate HBV clearance in coinfection. Virol Sin 2022:S1995-820X(22)00065-7. [PMID: 35523417 DOI: 10.1016/j.virs.2022.04.001] [Reference Citation Analysis]
7 Hanif FM, Majid Z, Luck NH, Tasneem AA, Laeeq SM, Mubarak M. Revolution in the diagnosis and management of hepatitis C virus infection in current era. World J Hepatol 2022; 14(4): 647-669 [DOI: 10.4254/wjh.v14.i4.647] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sampaio RMA, Dantas PEF, da Silva MIC, da Silva JR, Nunes PF, Gomes AC, Martins LC. Comparison of Patients Monoinfected with Hepatitis C Virus and Coinfected with Hepatitis B/C in the Amazon Region of Brazil. Viruses 2022;14:856. [DOI: 10.3390/v14050856] [Reference Citation Analysis]
9 Tseng C, Liu W, Chen C, Chang T, Tseng K. Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV. BMC Infect Dis 2022;22. [DOI: 10.1186/s12879-022-07326-1] [Reference Citation Analysis]
10 Zaongo SD, Ouyang J, Chen Y, Jiao Y, Wu H, Chen Y. HIV Infection Predisposes to Increased Chances of HBV Infection: Current Understanding of the Mechanisms Favoring HBV Infection at Each Clinical Stage of HIV Infection. Front Immunol 2022;13:853346. [DOI: 10.3389/fimmu.2022.853346] [Reference Citation Analysis]
11 Silva RCMC, Ribeiro JS, da Silva GPD, da Costa LJ, Travassos LH. Autophagy Modulators in Coronavirus Diseases: A Double Strike in Viral Burden and Inflammation. Front Cell Infect Microbiol 2022;12:845368. [DOI: 10.3389/fcimb.2022.845368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ko CC, Ho SY, Liu PH, Hsu CY, Hsia CY, Huang YH, Su CW, Lei HJ, Lee RC, Hou MC, Huo TI. Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin-bilirubin grade. Int J Clin Oncol 2022. [PMID: 35119581 DOI: 10.1007/s10147-022-02117-9] [Reference Citation Analysis]
13 Malik F, Chulanov V, Pimenov N, Fomicheva A, Lundin R, Levina N, Thorne C, Turkova A, Indolfi G. Treatment and monitoring of children and adolescents with hepatitis C in Russia: Results from a multi-centre survey on policy and practice. Journal of Virus Eradication 2022. [DOI: 10.1016/j.jve.2022.100063] [Reference Citation Analysis]
14 Krag A, Roskams T, Pinzani M, Mueller S. Diagnostic challenges in patients with alcohol-related liver disease. Z Gastroenterol 2022;60:45-57. [PMID: 35042253 DOI: 10.1055/a-1713-4372] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Jacob R, Danta M. Pharmacotherapeutic strategies for hepatitis B and hepatitis C coinfection. Expert Opin Pharmacother 2021;:1-8. [PMID: 34937470 DOI: 10.1080/14656566.2021.2019708] [Reference Citation Analysis]
16 Cheng Z, Lin P, Cheng N. HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases. Front Med (Lausanne) 2021;8:713981. [PMID: 34676223 DOI: 10.3389/fmed.2021.713981] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
17 Sudhindar PD, Wainwright D, Saha S, Howarth R, McCain M, Bury Y, Saha SS, McPherson S, Reeves H, Patel AH, Faulkner GJ, Lunec J, Shukla R. HCV Activates Somatic L1 Retrotransposition-A Potential Hepatocarcinogenesis Pathway. Cancers (Basel) 2021;13:5079. [PMID: 34680227 DOI: 10.3390/cancers13205079] [Reference Citation Analysis]
18 Ružić M, Rajić N, Fabri M, Urošević I, Jojkić MD, Preveden T, Pete M, Rajić N. Implementation of Microelimination Strategy in Eradication of Chronic Hepatitis C Infection in Patients with Hemophilia in the Northern region of Serbia: Is Eradication Possible? Mediterr J Hematol Infect Dis 2021;13:e2021058. [PMID: 34527210 DOI: 10.4084/MJHID.2021.058] [Reference Citation Analysis]
19 Bixler D, Annambhotla P, Montgomery MP, Mixon‐hayden T, Kupronis B, Michaels MG, La Hoz RM, Basavaraju SV, Kamili S, Moorman A. Unexpected hepatitis B virus infection after liver transplantation — United States, 2014–2019. Am J Transplant 2021;21:3190-5. [DOI: 10.1111/ajt.16045] [Reference Citation Analysis]
20 Huang X, Glessner JT, Huang J, Zhou D, March ME, Wang H, Xia Q, Hakonarson H, Li J. Discovery of Novel Host Molecular Factors Underlying HBV/HCV Infection. Front Cell Dev Biol 2021;9:690882. [PMID: 34458256 DOI: 10.3389/fcell.2021.690882] [Reference Citation Analysis]
21 Bendari M, Delsa H, Bouanani N, Jabouri R, Darouich S, Nejjari S, Guessous F, Doghmi K. Hemophagocytic lymphohistiocytosis associated with HBV-HCV coinfection in adult: Case report. Clin Case Rep 2021;9:e04328. [PMID: 34401150 DOI: 10.1002/ccr3.4328] [Reference Citation Analysis]
22 Dennis BB, Naji L, Jajarmi Y, Ahmed A, Kim D. New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years. World J Gastroenterol 2021; 27(29): 4818-4830 [PMID: 34447228 DOI: 10.3748/wjg.v27.i29.4818] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
23 Jia HD, Liang L, Li C, Wu H, Wang H, Liang YJ, Zhou YH, Gu WM, Fan XP, Zhang WG, Chen TH, Chen ZY, Zhong JH, Lau WY, Pawlik TM, Diao YK, Xu QR, Shen F, Zhang CW, Huang DS, Yang T. Long-Term Surgical Outcomes of Liver Resection for Hepatocellular Carcinoma in Patients With HBV and HCV Co-Infection: A Multicenter Observational Study. Front Oncol 2021;11:700228. [PMID: 34395268 DOI: 10.3389/fonc.2021.700228] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
24 Pérez-Latorre L, Berenguer J, Micán R, Montero M, Cifuentes C, Puig T, Sanz J, Ferrero OL, De La Fuente B, Rodríguez C, Reus S, Hernández-Quero J, Gaspar G, Pérez-Martínez L, García C, Force L, Veloso S, De Miguel M, Jarrín I, González-García J; GeSIDA 8514 Study Group. HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018. Euro Surveill 2021;26. [PMID: 34169818 DOI: 10.2807/1560-7917.ES.2021.26.25.2000236] [Reference Citation Analysis]
25 Bixler D, Annambhotla P, Montgomery MP, Mixon-Hayden T, Kupronis B, Michaels MG, La Hoz RM, Basavaraju SV, Kamili S, Moorman A. Unexpected Hepatitis B Virus Infection After Liver Transplantation - United States, 2014-2019. MMWR Morb Mortal Wkly Rep 2021;70:961-6. [PMID: 34237046 DOI: 10.15585/mmwr.mm7027a1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Mann P, Smith VA, Mitchell JBO, Dobson S. Cooperative coinfection dynamics on clustered networks. Phys Rev E 2021;103:042307. [PMID: 34005956 DOI: 10.1103/PhysRevE.103.042307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Abdulla M, Ghuloom M, Nass H, Mohammed N, Farid E, ALQamish J. Prevalence of hepatitis B e antigenemia in Bahraini hepatitis B patients: A retrospective, single-center study. JGH Open 2021;5:337-42. [PMID: 33732879 DOI: 10.1002/jgh3.12494] [Reference Citation Analysis]
28 Cheng X, Uchida T, Xia Y, Umarova R, Liu CJ, Chen PJ, Gaggar A, Suri V, Mücke MM, Vermehren J, Zeuzem S, Teraoka Y, Osawa M, Aikata H, Tsuji K, Mori N, Hige S, Karino Y, Imamura M, Chayama K, Liang TJ. Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection. J Clin Invest 2020;130:3205-20. [PMID: 32163375 DOI: 10.1172/JCI135616] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 19.0] [Reference Citation Analysis]
29 Weng JJ, Wei JZ, Li M, Lu JL, Qin YD, Jiang H, Qu SH. Effects of hepatitis B virus infection and antiviral therapy on the clinical prognosis of nasopharyngeal carcinoma. Cancer Med 2020;9:541-51. [PMID: 31774249 DOI: 10.1002/cam4.2715] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
30 Wang X, Wu B. Critical issues in the diagnosis and treatment of liver cirrhosis. Gastroenterol Rep (Oxf) 2019;7:227-30. [PMID: 31413829 DOI: 10.1093/gastro/goz024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
31 Weber J, Sahoo MK, Taylor N, Shi RZ, Pinsky BA. Evaluation of the Aptima HCV Quant Dx Assay Using Serum and Dried Blood Spots. J Clin Microbiol 2019;57:e00030-19. [PMID: 30760534 DOI: 10.1128/JCM.00030-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
32 Cohen-Bucay A, Gordon CE, Francis JM. Non-immunological complications following kidney transplantation. F1000Res. 2019;8. [PMID: 30828430 DOI: 10.12688/f1000research.16627.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]